Omnicare

Consumer ServicesRetailFood & Drug Retailers
    
    
      Economy, Business And Finance
        Company InformationMerger, Acquisition And Takeover
      Health
        Health Organisations
    

    


COVINGTON, Ky., August 25, 2011 - Omnicare, Inc. (NYSE:OCR) today issued the
following statement in response to PharMerica Corporation's (NYSE: PMC) August
24, 2011 press release:

"We are encouraged by PharMerica's statement that its Board of Directors is open
to exploring all opportunities to maximize stockholder value.  With a $15 per
share all cash proposal on the table, we should be included in the strategic
alternatives process that we understand PharMerica has been conducting for
several months.

"While we have a number of disagreements about PharMerica's characterizations of
our discussions, we remain willing, as we previously indicated, to discuss ways
to reasonably allocate the regulatory risk, if any, in the context of broader
discussions about a combination of our two companies.  We are also willing, as
we have stated to PharMerica previously, to use a third party with respect to
the exchange of confidential information.

"We remain firmly committed to pursuing this transaction and have instructed our
advisors to reach out to PharMerica to initiate these actions."

Goldman, Sachs & Co. is acting as financial advisor to Omnicare and Dewey &
LeBoeuf LLP and Axinn, Veltrop & Harkrider LLP are acting as legal counsel.

About Omnicare

Omnicare, Inc., a Fortune 400 company based in Covington, Kentucky, provides
comprehensive pharmaceutical services to patients and providers across North
America.  As the market-leader in professional pharmacy, related consulting and
data management services for skilled nursing, assisted living and other chronic
care institutions, Omnicare leverages its unparalleled clinical insight into the
geriatric market along with some of the industry's most innovative technological
capabilities to the benefit of its long-term care customers.  Omnicare also
provides key commercialization services for the bio-pharmaceutical industry and
end-of-life disease management through its Specialty Care Group.  For more
information, visit www.omnicare.com.

Forward-looking Statements

In addition to historical information, this press release contains certain
statements that constitute "forward-looking statements."  These forward-looking
statements include, but are not limited to, all statements regarding the intent,
belief or current expectations regarding the matters discussed or incorporated
by reference in this document (including, but not limited to, statements as to
"beliefs," "expectations," "anticipations," "intentions" or similar words) and
all statements which are not statements of historical fact.  Such forward-
looking statements, together with other statements that are not historical, are
based on management's current expectations and involve known and unknown risks,
uncertainties, contingencies and other factors that could cause results,
performance or achievements to differ materially from those stated.  These risks
and uncertainties include, but are not limited to, the possibility that Omnicare
will not pursue a transaction with PharMerica, the timing to consummate a
potential transaction between Omnicare and PharMerica, the ability and timing to
obtain required regulatory approvals, Omnicare's ability to realize the
synergies contemplated by a potential transaction, Omnicare's ability to
promptly and effectively integrate the businesses of PharMerica and Omnicare,
the performance of Omnicare's institutional pharmacy business, business
conditions in the institutional pharmacy industry generally, the inability to
expand geographically as anticipated, the inability to leverage services and
capabilities among Omnicare's network of institutional pharmacies as
anticipated, the effectiveness of Omnicare's strategy in the institutional
pharmacy business, the ability of the PharMerica acquisition to strengthen
relationships with pharmaceutical and biotechnology companies and the risks and
uncertainties described in Omnicare's Form 10-K, Form 10-Q and Form 8-K reports
filed with the Securities and Exchange Commission.  Should one or more of these
risks or uncertainties materialize or should underlying assumptions prove
incorrect, Omnicare's actual results, performance or achievements could differ
materially from those expressed in, or implied by, such forward-looking
statements.  Readers are cautioned not to place undue reliance on these forward-
looking statements, which speak only as of the date hereof.  Except as otherwise
required by law, Omnicare does not undertake any obligation to publicly release
any revisions to these forward-looking statements to reflect events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events.

Important Additional Information

This communication does not constitute an offer to buy or solicitation of an
offer to sell any securities. No tender offer for the shares of PharMerica
Corporation ("PharMerica") has commenced at this time. In connection with the
proposed transaction, Omnicare, Inc. ("Omnicare") may file tender offer
documents with the U.S. Securities and Exchange Commission ("SEC"). Any
definitive tender offer documents will be mailed to stockholders of PharMerica.
INVESTORS AND SECURITY HOLDERS OF PHARMERICA ARE URGED TO READ THESE AND OTHER
DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME
AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED
TRANSACTION. Investors and security holders of PharMerica will be able to obtain
free copies of these documents (if and when available) and other documents filed
with the SEC by Omnicare through the web site maintained by the SEC at
http://www.sec.gov or by directing a request to the Corporate Secretary of
Omnicare, Inc., 100 East RiverCenter Boulevard, Suite 1600, Covington, Kentucky
41011.

                                     # # #

Contacts:

Omnicare
Patrick C. Lee
(859) 392-3444
patrick.lee@omnicare.com

Joele Frank, Wilkinson Brimmer Katcher
Andy Brimmer / Jamie Moser
(212) 355-4449
abrimmer@joelefrank.com
jmoser@joelefrank.com






This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: Omnicare via Thomson Reuters ONE

[HUG#1541093]